Position in PRGO
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$447,694
-$16,703 QoQ
Shares Held
43,089
-0.3% QoQ
Ownership
0.031%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#133
of 334 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in PRGO Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026QUADRANT CAPITAL GROUP LLC holds $12,861,475 across 15 Drug Manufacturers - Specialty & Generic names. PRGO ranks #9 (3.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | UTHR |
UNITED THERAPEUTICS Corp
|
4,959 | $2,686,934 | |
| 2 | RDY |
Dr Reddys Laboratories Ltd
|
111,861 | $1,620,865 | |
| 3 | NBIX |
Neurocrine Biosciences Inc
|
8,171 | $1,377,140 | |
| 4 | TAK |
Takeda Pharmaceutical Co Ltd
|
81,606 | $1,308,144 | |
| 5 | VTRS |
Viatris Inc
|
71,967 | $1,142,835 | |
| 6 | LNTH |
Lantheus Holdings, Inc.
|
7,926 | $879,310 | |
| 7 | TEVA |
Teva Pharmaceutical Industries Ltd
|
23,551 | $797,907 | |
| 8 | ALKS |
Alkermes plc.
|
13,278 | $695,767 |
All Filings in PRGO
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $447,694 | 43,089 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $464,397 | 43,240 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $620,261 | 44,559 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $983,554 | 44,165 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $1,206,701 | 45,161 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $1,693,419 | 60,393 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $1,109,540 | 43,156 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $1,130,381 | 43,095 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $1,109,940 | 43,222 | Shares | Sole | 2024-08-12 | |
| 2024-03-31 | $1,459,011 | 45,325 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $510,278 | 15,857 | Shares | Sole | 2024-02-08 | |
| 2023-09-30 | $11,789 | 369 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $33,950 | 1,000 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $55,526 | 1,548 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $11,488 | 337 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $12,944 | 363 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $2,961 | 73 | Shares | Sole | 2022-08-09 | |
| 2022-03-31 | $922 | 24 | Shares | Sole | 2022-05-06 | |
| 2021-12-31 | $1,089 | 28 | Shares | Sole | 2022-02-01 | |
| 2021-09-30 | $3,739 | 79 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $5,731 | 125 | Shares | Sole | 2021-08-09 | |
| 2021-03-31 | $5,827 | 144 | Shares | Sole | 2021-05-12 | |
| 2020-12-31 | $25,266 | 565 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $23,551 | 513 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $15,420 | 279 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $171,676 | 3,570 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||